Notice of Preliminary Results

Oxford, UK – 7 March 2016: Circassia Pharmaceuticals plc (LSE: CIR), a specialty biopharmaceutical company focused on allergy and respiratory medicine, will announce its preliminary results for the year ended 31 December 2015 on Friday 11 March 2016.

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company’s website.

For further information please contact:

FTI Consulting
Mo Noonan / Matt Moss
+44 (0) 20 3727 1000